Stratenym was created as a direct response to our clients’ need for hands-on experts who thrive on strategy and who can distill evidence into compelling value-driven content that resonates with payers. For each mandate, we curate a team of top-tier market access, communications, and research experts from our network to deliver personalized and quality support to our clients in the pharmaceutical and devices space. With a solid track record as trusted advisors, we enable our clients to focus on the bigger picture so that they can achieve their goals seamlessly. Our substantial experience in delivering on complex mandates brings our clients back again and again.
Leadership
W. Mark Roberts
Vice President, Medical Communications
BSc (Hons) & MSc, University of British Columbia;
MA & PhD, Princeton University
Mark combines an editor’s eye for detail with the big-picture insights he has gained over 17 years in the field of health economics and outcomes research. Mark leverages his extensive experience as a manager of content-development teams and as a hands-on medical writer and editor to ensure the high quality of our deliverables.
Successfully transitioning from academia to industry in 2003, Mark has built deep experience in developing medical communications in a broad range of therapeutic areas, with a strong focus on orphan indications. He is an expert on effective presentation of research findings, including for such specialized topics as cost-effectiveness analysis, retrospective database analysis, and patient-reported outcomes. Over his long career in the field, he has supported the development of global value dossiers, strategy documents to help companies differentiate their products from the competition, articles for peer-reviewed biomedical journals, pharmacoeconomic model reports, and conference abstracts, posters and slide decks.
From 2006–2009, Mark was the Managing Editor at IC Axon, where he supervised the medical writer team creating content for innovative sales training for clients in the pharmaceutical industry. Prior to this position, Mark was a Senior Research Application Associate at BioMedCom Consultants, where he developed projects for clients in industry and academia. He has also taught courses in biostatistics and experimental methods at McGill University.
Sabrina Smith
Vice President, Strategy and Value
BSc, Dalhousie University;
MSc, McGill University
Sabrina provides hands-on strategic guidance on Stratenym projects with a focus on highlighting product value. With 15+ years of experience in developing communications for diverse audiences, including payers, physicians, researchers, and pharmaceutical executives, she is an expert at extracting and conveying compelling value messages from clinical data.
Sabrina has more than 15 years of experience in medical communications. Over the span of her career, she has worked with a diverse group of Fortune 500 pharma companies, biotech startups, non-profit organizations, and academia. At Stratenym, she provides strategic guidance on medical communications and market access initiatives, as well as directly developing scientific content.
Sabrina has experience in several therapeutic areas, including oncology, infectious disease and immunology, gastroenterology, cardiology, rheumatology, endocrinology, neurology, and hematology. Her past projects include international disease awareness campaigns, global value dossiers, payer value messages, HTA and reimbursement submissions, conference abstracts and presentations, systematic literature reviews, as well as comparative effectiveness research and targeted research on patient-reported outcomes. With expertise in value-driven and evidence-based communications, her work has led to several HTA agency recommendations for product reimbursement.
Prior to Stratenym, Sabrina held senior roles at two international communications companies where she led teams on several high-profile sales training, disease awareness, and market access initiatives.
Shawn mcdonald
director of operations
BKin., BEd., MBA, University of Calgary
Shawn’s mandate is to support all functions within Stratenym to drive process efficiency and best practices across operations, overseeing our PMO, administrative, and finance functions. He has a client-centric approach, always making partner success the top priority.
Shawn brings 18+ years of progressive leadership experience in operational roles that include management of multi-unit, cross-functional teams in environments that can be described as fast-paced, ambiguous, and challenging. He has direct experience working with traditional brands delivering consumer goods and services at the retail, wholesale, and distribution levels as well as managing digital-first and tech enabled brands operating globally.
Throughout his career Shawn has worked within highly regulated industries that are globally connected and has a deep understanding between executing on delivery while integrating external stakeholder requirements.
Maintaining a steadfast desire to engage and fulfill the needs of stakeholders and clients alike, Shawn takes a client and customer-centric approach when framing internal processes, always making partner success the top priority.
Featured Consultants
Georghia Michael
PhD, Uni of Strathclyde; MWC (AMWA)
Georghia uses her natural talent for content development to successfully distill and communicate complex medical evidence on Stratenym projects.
She brings extensive healthcare knowledge and 10+ years of experience writing for different audiences in the fields of cardiology, endocrinology, dermatology, oncology, gastroenterology, hematology, and rheumatology.
Angela Styhler
MSc, McGill University
Angela has 10+ years of experience as a medical writer, leveraging her 10+ years of experience in academic and pharmaceutical research to prepare content for a wide range of clients.
Her areas of expertise include psychiatric disorders, infectious diseases, oncology, immunology, metabolic disorders and inflammatory diseases.
Jake Astill
MSc, University of Guelph
With an academic background in microbiology and immunology, Jake is a skilled research writer with over 25 peer-reviewed publications. He has previously led communications with regulatory agencies.
At Stratenym, Jake formulates strategic guidance for our clients, notably spearheading a new algorithm on selecting and optimizing value messaging for different contexts. Jake has contributed to core value dossiers and submissions to HTA agencies in the UK, Canada, and Australia, with a strong focus on therapies for rare diseases.
Community
Stratenym is proud to recommend and collaborate with the following companies to offer full-service solutions to our clients:
